Implementing Evidence Based Practices For Treatment Of Alcohol And Drug Disorders

"Implementing Evidence-Based Practices for Treatment of Alcohol and Drug Disorders" provides managers and clinicians with results from Practice Improvement Collaboratives (PIC) that demonstrate how substance abuse treatment can be improved by increasing the exchange of knowledge between community-based service providers and the research community. The book examines improvement collaboratives and mentoring strategies for adopting and using evidence-based practices. Contributors address how to determine the best treatment processes to serve clients, how to deal with the hurdles faced in preparing and training counsellors, and how to affect the needed changes in agency activities. This unique professional resource responds to an Institute of Medicine report that found a substantial disconnect between research and practice in treatment for drug and alcohol dependence. Focusing on how to make the changes necessary to support the adoption and use of evidence-based practices, the book documents the activities of four sites to illustrate how investigators and treatment practitioners worked together to implement evidence-based practices. Contributors examine the development and early implementation of Practice Improvement Collaboratives, the investigator-provider-policymaker model, Motivational Enhancement Therapy, the use of Opinion Leaders in training, and targeted strategies that take into account the differences in clinician demographics and training. "Implementing Evidence-Based Practices for Treatment of Alcohol and Drug Disorders" is an essential tool for alcohol and drug counsellors, directors of alcohol and drug treatment clinics, and instructors in counsellor training and academic programs.

This book is an attempt to bridge the gap between research on substance abuse treatment programs and what actually goes on in the field of substance abuse treatment. It is aimed at both the academic and practitioner market (as is Perkinson) and it clearly describes how to determine what evidence based practice is and it addresses some of the challenges that practioners and agency directors might face in implementing EBP. The book is well-written and highly practical. It contains two complete case studies that outline two examples of Evidence based practice which will be particularly useful in the course market.

All across the United States, individuals, families, communities, and health care systems are struggling to cope with substance use, misuse, and substance use disorders. Substance misuse and substance use disorders have devastating effects, disrupt the future plans of too many young people, and all too often, end lives prematurely and tragically. Substance misuse is a major public health challenge and a priority for our nation to address. The effects of substance use are cumulative and costly for our society, placing burdens on workplaces, the health care system, families, states, and communities. The Report discusses opportunities to bring substance use disorder treatment and mainstream health care systems into alignment so that they can address a person's overall health, rather than a substance misuse or a physical health condition alone or in isolation. It also provides suggestions and recommendations for action that everyone-individuals, families, community leaders, law enforcement, health care professionals, policymakers, and researchers-can take to prevent substance misuse and reduce its consequences.

The guideline focuses specifically on evidence-based pharmacological treatments for AUD in outpatient settings and includes additional information on assessment and treatment planning, which are an integral part of using pharmacotherapy to treat AUD.

Estimates indicate that as many as 1 in 4 Americans will experience a mental health problem or will misuse alcohol or drugs in their lifetimes. These disorders are among the most highly stigmatized health conditions in the United States, and they remain barriers to full participation in society in areas as basic as education, housing, and employment. Improving the lives of people with mental health and substance abuse disorders has been a priority in the United States for more than 50 years. The Community Mental Health Act of 1963 is considered a major turning point in America's efforts to improve behavioral healthcare. It ushered in an era of optimism and hope and laid the groundwork for the consumer movement and new models of recovery. The consumer movement gave voice to people with mental and substance use disorders and brought their perspectives and experience into national discussions about mental health. However over the same 50-year period, positive change in American public attitudes and beliefs about mental and substance use disorders has lagged behind these advances. Stigma is a complex social phenomenon based on a relationship between an attribute and a stereotype that assigns undesirable labels, qualities, and behaviors to a person with that attribute. Labeled individuals are then socially devalued, which leads to inequality and discrimination. This report contributes to national efforts to understand and change attitudes, beliefs and behaviors that can lead to stigma and discrimination. Changing stigma in a lasting way will require coordinated efforts, which are based on the best possible evidence, supported at the national level with multiyear funding, and planned and implemented by an effective coalition of representative stakeholders. Ending Discrimination Against People with Mental and Substance Use Disorders: The Evidence for Stigma Change explores stigma and discrimination faced by individuals with mental or substance use disorders and recommends effective strategies for reducing stigma and encouraging people to seek treatment and other supportive services. It offers a set of conclusions and recommendations about successful stigma change strategies and the research needed to inform and evaluate these efforts in the United States.

Evidence-Based Treatments for Alcohol and Drug Abuse encompasses the developments in the field over the last decade, blending theory, techniques and clinical flexibility. Research in the past decade has shown that substance abuse and substance dependence are treatable. The field has witnessed the introduction of evidence-based psychological and specific pharmacological treatments. Unfortunately, many of the empirical supported therapies for addictions are still not widely applied by practitioners. The third volume in the Practical Clinical Guidebooks Series (PCG), Evidence-Based Treatments for Alcohol and Drug Abuse, defines the characteristics, classification, and prevalence of substance use disorders, and provides the clinician with practical guidelines applicable across a variety of treatment settings and patient groups. Drawing on the recent research in the field, the authors provide the practicing clinician and student with an up-to-date understanding of the epidemiology, etiology, course and prognosis of substance abuse disorders that would be relevant to clinical practice. In addition to describing phenomenology and etiology, the book provides a comprehensive guide to the assessment and treatment of DSM-IV-TR substance abuse disorders (SUDs), including abuse and dependence of alcohol, stimulants, opiates, hallucinogens, cannabis/marijuana, sedative, and party drugs.

Today, most substance abuse treatment is administered by community-based organizations. If providers could readily incorporate the most recent advances in understanding the mechanisms of addiction and treatment, the treatment would be much more effective and efficient. The gap between research findings and everyday treatment practice represents an enormous missed opportunity at this exciting time in this field. Informed by real-life experiences in addiction treatment including workshops and site visits, Bridging the Gap Between Practice and Research examines why research remains remote from treatment and makes specific recommendations to community providers, federal and state agencies, and other decision-makers. The book outlines concrete strategies for building and disseminating knowledge about addiction; for linking research, policy development, and everyday treatment implementation; and for helping drug treatment consumers become more informed advocates. In candid language, the committee discusses the policy barriers and the human attitudesâ€"the stigma, suspicion, and skepticismâ€"that often hinder progress in addiction treatment. The book identifies the obstacles to effective collaboration among the research, treatment, and policy sectors; evaluates models to address these barriers; and looks in detail at the issue from the perspective of the community-based provider and the researcher.

What are the most promising strategies to treat alcohol and drug abuse? What are their medical implications? Despite the enormous resources spent on treating alcoholism and drug dependence, there is still no satisfactory evaluation of their effectiveness or of the cost of the different alternatives. Programs designed to treat substance abuse should be built on a foundation of evidence-based knowledge. Yet it is almost impossible to cope with the increasing amount of scientific literature. This book thus represents a guide through the myriads of articles. The most comprehensive scientific review of its kind, it presents the findings from more than 1,600 studies on the effectiveness of different treatments. The work also includes a summary of the methods available to intervene against harmful levels of alcohol, with most of the studies making use of the Diagnostic and Statistical Manual of Mental Disorders (DSM) system. The extensive results are arranged in detailed tables, which may be searched using the accompanying CD-ROM. Also enclosed are a quality checklist and an extensive glossary explaining more than 70 terms. An invaluable tool for medical researchers, clinicians and doctors as well as healthcare providers and insurers, allowing them to save major resources by identifying ineffective treatments and being aware of cost-effective alternatives. With a foreword by Henry R. Kranzler, University of Connecticut, USA.